Imperial Capital Cuts Price Target on Imperva (IMPV) Following 1Q; Awaiting Turnaround Progress
Tweet Send to a Friend
Imperial Capital maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $55.00 (from $70.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
